Skip to main content
An official website of the United States government

Global Tobacco Control Research

A doctor wearing a protective mask uses a stethoscope to listen to the heartbeat and breathing of an elderly woman
Credit: M2020

Overview

The Center for Global Health (CGH) leads international research initiatives on how to control global tobacco use with the goal of reducing related cancers and other diseases worldwide.

Impact

Tobacco use is a leading cause of preventable cancer mortality worldwide, responsible for about 25% of cancer deaths and 70% of lung cancer deaths. 

While tobacco use and related mortality has been declining in many high-income countries, this trend does not extend to many low- and middle-income countries (LMICs), where 84% of the world’s 1.3 billion current smokers reside. While a large body of tobacco control research has been generated in high-income countries, this work is only partly applicable to the evolving social, economic, and cultural climate of many LMICs. Expanding tobacco control research and research capacity in LMICs is crucial to reducing tobacco use and cancer rates worldwide.

Tobacco Control Research Funding

Since 2000, NCI has supported grants to conduct research in more than 50 countries to study the use and characteristics of diverse tobacco products, evaluate low-cost tobacco cessation interventions, and assess tobacco control policies in distinct environments. Most recently, CGH has supported tobacco cessation interventions tailored to HIV-positive populations, including those with comorbidities such as tuberculosis, in low-resource settings. CGH supports a growing portfolio of tobacco control research in LMICs, including studying the implementation of effective tobacco cessation interventions in LMICs and evaluating interventions tailored to HIV-positive populations in low-resource settings. CGH has also worked with the Fogarty International Center to support the International Tobacco and Health Research and Capacity Building Program.

See more information about NCI's tobacco and HIV research.

See current CGH funding opportunities.

See NCI tobacco control funding opportunities that may be open to international applications. 

See examples of current and recently funded grants for global tobacco control.

PI Name Organization Name Project Title Grant Number
Glorian C. Sorensen   Dana-Farber Cancer Inst Disseminating an Evidence-Based Tobacco Control intervention for School Teachers in India R01CA200691
Ritesh Mistry University of Michigan at Ann Arbor Longitudinal Study of Adolescent Tobacco Use and Tobacco Control Policy in India R01CA201415
Seth Himelhoch University of Maryland at Baltimore Optimizing Smoking Cessation Interventions for PLWH in Nairobi, Kenya R01CA225419
Lisa Quintiliani Boston Medical Center Quit for Life (QFL): Smoking Cessation Among Chinese Smokers Living with HIV R21CA243835
Donna Shelley New York University Implementing Tobacco Use Treatment in HIV Clinics in Vietnam R01CA240481
Kasisomayajula Viswanath Dana-Farber Cancer Inst Adapting and evaluating a brief advice tobacco intervention in high-reach, low-resource settings in India R01CA230355
Heather Wipfli University of Southern California Quit4Life+: Adapting and Evaluating a Phone-Based Tobacco Use Cessation Program for People Living with HIV in Uganda and Zambia U01CA261624
Damon Vidrine H. Lee Moffitt Cancer Ctr & Res Inst Ending Tobacco Use through Interactive Tailored Messaging for Cambodian People Living with HIV/AIDS (EndIT) U01CA261598
Rajani Sadasivam Univ of Massachusetts Med Sch Worcester mHealth Messaging to Motivate Quitline use and Quitting among Persons Living with HIV in Vietnam (M2Q2-HIV) U01CA261604
Jonathan Golub Johns Hopkins University Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness U01CA261626
Stella Bialous University of California, San Francisco Integrating Tobacco Use Cessation Into HIV Care and Treatment in Ministry of Health Facilities in Kisumu County Kenya U01CA261620
Gina Kruse Massachusetts General Hospital Varenicline and mobile behavioral assistance for tobacco cessation in HIV care in India U01CA261614

How to Connect

For information, contact program directors Marie Ricciardone, Ph.D., or Mark Parascandola, Ph.D., M.P.H. 

Helpful Tools

NCI established the Tobacco Control Monograph Series to provide ongoing and timely information about emerging public health issues in smoking and tobacco use control. NCI partnered with the World Health Organization to develop Monograph 21: The Economics of Tobacco and Tobacco Control, which examines the current research and evidence base surrounding the economics of tobacco control.  

Find information on international grants, global resources, and ongoing activities with the Division of Cancer Control and Population Sciences Tobacco Control Research Branch international and global health activities.

Email